Eribulin Mesylate
- Strength
- .5 mg/mL
- Form
- Solution
- Class
- Microtubule Inhibitor
BluePoint Laboratories
Not stocked by us — reference only
Listed by Kindos Pharmaceuticals Co., Ltd.
| Dosage form | Injection |
|---|---|
| Route | Intravenous |
| Drug class | Microtubule Inhibitor |
| Approval route | ANDA — approved generic |
| NDC code | 40033-364 |
| FDA application | ANDA218142 |
| RxNorm concept | 1045456 |
| Package sizes listed | 1 |
| Marketed since | August 2025 |
Same active ingredient, different manufacturer, strength or form. Products matching on both ingredient and strength are usually interchangeable — but confirm before switching, especially with modified-release forms.
BluePoint Laboratories
Not stocked by us — reference only
Baxter Healthcare Company
Not stocked by us — reference only
Gland Pharma Limited
Not stocked by us — reference only
Sun Pharmaceutical Industries Limited
Not stocked by us — reference only
HIKMA PHARMACEUTICALS USA INC.
Not stocked by us — reference only
Dr. Reddys Laboratories Inc
Not stocked by us — reference only
Apotex Corp.
Not stocked by us — reference only
GLENMARK PHARMACEUTICALS INC., USA
Not stocked by us — reference only
Information only, not medical advice. Nothing on this page indicates that a medication is safe or suitable for you. Speak to a prescriber or pharmacist before starting, stopping or switching any medicine.
Please don't share card details in chat.